000 | 01941 a2200565 4500 | ||
---|---|---|---|
005 | 20250517163414.0 | ||
264 | 0 | _c20180510 | |
008 | 201805s 0 0 eng d | ||
022 | _a1422-0067 | ||
024 | 7 |
_a10.3390/ijms18071513 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMetzemaekers, Mieke | |
245 | 0 | 0 |
_aGlycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling. _h[electronic resource] |
260 |
_bInternational journal of molecular sciences _cJul 2017 |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 |
_aCell Membrane _xdrug effects |
650 | 0 | 4 | _aChemokine CXCL10 |
650 | 0 | 4 |
_aChemotaxis, Leukocyte _xdrug effects |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 | _aCricetulus |
650 | 0 | 4 |
_aDipeptidyl Peptidase 4 _xmetabolism |
650 | 0 | 4 |
_aGlycosaminoglycans _xpharmacology |
650 | 0 | 4 |
_aHeparin _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
650 | 0 | 4 |
_aJoints _xdrug effects |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 |
_aProteolysis _xdrug effects |
650 | 0 | 4 |
_aReceptors, CXCR3 _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aSitagliptin Phosphate _xpharmacology |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
700 | 1 | _aMortier, Anneleen | |
700 | 1 | _aJanssens, Rik | |
700 | 1 | _aBoff, Daiane | |
700 | 1 | _aVanbrabant, Lotte | |
700 | 1 | _aLamoen, Nicole | |
700 | 1 | _aVan Damme, Jo | |
700 | 1 | _aTeixeira, Mauro M | |
700 | 1 | _aDe Meester, Ingrid | |
700 | 1 | _aAmaral, Flávio A | |
700 | 1 | _aProost, Paul | |
773 | 0 |
_tInternational journal of molecular sciences _gvol. 18 _gno. 7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3390/ijms18071513 _zAvailable from publisher's website |
999 |
_c27363847 _d27363847 |